POMALYST REMS
USPTO Trademark Record · Serial No. 85894252
Trademark details
It was initially claimed by Celgene Corporation on 20130403.
That brand applies to the following goods and services:Disease management and treatment programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; disease management and treatment programs that provide counseling and information regarding the pharmaceutical drug pomalidomide, and distributing written materials in connection therewith, Government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, including counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith; government pharmaceutical programs that provide medical counseling and medical information regarding the pharmaceutical drug pomalidomide and safety issues pertaining to consumers' use of the pharmaceutical drug.
Currently that trademark is represented by trademark attorney(s): Camille M. Miller.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the POMALYST REMS trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
